| 000 | 01623 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515201702.0 | ||
| 264 | 0 | _c20100303 | |
| 008 | 201003s 0 0 eng d | ||
| 022 | _a1748-717X | ||
| 024 | 7 |
_a10.1186/1748-717X-4-67 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGuckenberger, Matthias | |
| 245 | 0 | 0 |
_aProspective phase II study of preoperative short-course radiotherapy for rectal cancer with twice daily fractions of 2.9 Gy to a total dose of 29 Gy--long-term results. _h[electronic resource] |
| 260 |
_bRadiation oncology (London, England) _cDec 2009 |
||
| 300 |
_a67 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aAntineoplastic Agents |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aDigestive System Surgical Procedures |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoadjuvant Therapy _xadverse effects |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aRadiotherapy _xadverse effects |
| 650 | 0 | 4 | _aRadiotherapy Dosage |
| 650 | 0 | 4 |
_aRectal Neoplasms _xmortality |
| 700 | 1 | _aWulf, Joern | |
| 700 | 1 | _aThalheimer, Andreas | |
| 700 | 1 | _aWehner, Daniel | |
| 700 | 1 | _aThiede, Arnulf | |
| 700 | 1 | _aMüller, Gottfried | |
| 700 | 1 | _aSailer, Marco | |
| 700 | 1 | _aFlentje, Michael | |
| 773 | 0 |
_tRadiation oncology (London, England) _gvol. 4 _gp. 67 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/1748-717X-4-67 _zAvailable from publisher's website |
| 999 |
_c19406512 _d19406512 |
||